iBio (IBIO) FCF Margin (QoQ) (2011 - 2025)
iBio (IBIO) FCF Margin (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - |
| 10 | iBio | 169.83 Mn | 169.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -339,650.00 |
| Sep 30, 2021 | -1.05 Mn |
| Jun 30, 2021 | -89,325.00 |
| Mar 31, 2021 | 24,472.00 |
| Dec 31, 2020 | 49,141.00 |
| Sep 30, 2020 | -140,926.00 |
| Jun 30, 2020 | 359,830.00 |
| Mar 31, 2020 | -286,690.00 |
| Dec 31, 2019 | 96,887.00 |
| Sep 30, 2019 | -154,703.00 |
| Jun 30, 2019 | 23,835.00 |
| Mar 31, 2019 | -3,411.00 |
| Dec 31, 2018 | 156,297.00 |
| Sep 30, 2018 | 161,497.00 |
| Jun 30, 2018 | 109,212.00 |
| Mar 31, 2018 | -258,147.00 |
| Dec 31, 2017 | 8,824.00 |
| Sep 30, 2017 | 35,925.00 |
| Jun 30, 2017 | 744,317.00 |
| Mar 31, 2017 | -541,672.00 |